Is SRAD a Buy or a Sell? The Bull and Bear Case (2026)
Last updated October 2026
Short answer
Both cases are real, which is why the question is contested. The bull case for Sportradar Group AG (SRAD) rests on Duopoly moat in official sports data: Sportradar and Genius Sports control the market for official, low-latency sports data that regulated sportsbooks depend on. The bear case rests on the largest risk is the cost of official league data rights, which come up for renewal every several years and are increasingly priced in cash plus equity stakes, diluting shareholders and pressuring margins. Analysts covering it publish targets from $13.68 to $35.78 against a $11.91 price, so even the professionals disagree by 121% of their own average. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.
Sportradar Group AG (Nasdaq: SRAD) is a B2B sports technology company that collects, models, and distributes real-time sports data. It sits between the leagues (from whom it licenses official data rights across soccer, tennis, basketball, and more) and its customers (sportsbooks, casinos, media companies, and leagues themselves), supplying live odds, managed trading services, integrity monitoring, and advertising and marketing tools. Crucially, Sportradar does not take bets or act as a bookmaker, so its economics track the overall growth of regulated betting rather than the win-or-lose outcome of any single wager. Its 2024 acquisition of IMG ARENA's global betting rights portfolio deepened its official-data moat. The investment picture is a growth-plus-margin story wrapped around a two-player market. Sportradar and Genius Sports form a duopoly for official sports data, and Sportradar is the older, larger, and profitable incumbent. Revenue has compounded at a double-digit-to-mid-20s percent pace, reaching about €1.29 billion in 2025 with about €100 million of profit, and management has leaned into shareholder returns with an accelerated buyback. The bull case rests on operating leverage, U.S. betting growth, and an emerging prediction-markets tailwind; the bear case centers on the escalating cost of league data rights (increasingly demanding equity, not just cash), FX drag, and the risk of losing a marquee rights contract. 2026 has been a hard year for the shares. Q1 revenue rose about 11% (16% in constant currency) but came with a small net loss, and Q2 2026 revenue of about €378 million grew roughly 19% while the company again reported a small net loss and adjusted EPS of $0.04 against a $0.07 consensus. Alongside Q2, Sportradar cut its 2026 outlook and announced a further buyback; one fund manager that sold its stake cited weaker reported earnings and restructuring costs. Operationally, Sportradar expanded its Polymarket partnership in August to cover more than 20 sports leagues and competitions, extended its Euroleague Basketball betting rights, and on October 7 agreed to sell Atrium Sports, the Synergy coaching and scouting business, to Teamworks for $170 million in cash, with closing expected in Q4 2026. As of October 16 the stock closes near $11.84, close to its 52-week low, against an average analyst target near $18. Q3 2026 results are scheduled for November 4.
The bull case: what would have to be true for $35.78
The most optimistic published target on SRAD is $35.78, +200.4% from the $11.91 price as of October 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.
1. Duopoly moat in official sports data
Sportradar and Genius Sports control the market for official, low-latency sports data that regulated sportsbooks depend on. Sportradar's scale across the most-bet global sports (soccer, tennis, basketball) and its IMG ARENA rights portfolio give it broad coverage that is hard for a third entrant to replicate. That structural position underpins pricing power and recurring, contract-based revenue.
2. Margin expansion and cash generation
Management has framed the model around adjusted EBITDA growing faster than revenue, and trailing operating cash flow of about €429 million and free cash flow near €347 million remain strong relative to a net-cash balance sheet (about €251 million of cash against €61 million of debt). The company launched a $250 million accelerated share buyback and added to buybacks with its Q2 2026 report. Reported profitability has lagged, though: trailing net margin is near 1% and 2026 guidance was cut, so the operating-leverage thesis is less proven than it looked earlier in the year.
3. U.S. growth and prediction-market optionality
Continued state-by-state legalization of U.S. sports betting expands Sportradar's addressable market, and its non-betting offerings (marketing, media, integrity services) are growing quickly. A newer catalyst is prediction markets like Kalshi and Polymarket, where Sportradar could supply official data to a fresh category of exchanges, though the regulatory status of sports-event contracts remains unsettled. That optionality became more concrete in August 2026, when Sportradar and Polymarket expanded their partnership to more than 20 global sports leagues and competitions, and the shares rose on the news.
4. IMG ARENA integration and portfolio pruning
The absorbed IMG ARENA rights broaden Sportradar's exclusive content and give it more products to cross-sell into existing sportsbook clients, and the August 2026 Euroleague Basketball extension renewed another official data and audiovisual rights deal. Sportradar is also trimming non-core assets: in October 2026 it agreed to sell Atrium Sports, Synergy's coaching and scouting business, to Teamworks for $170 million in cash, a price it described as a double-digit EBITDA multiple, with proceeds going to the balance sheet and capital allocation.
The bear case: what would have to be true for $13.68
The most pessimistic published target is $13.68, +14.9% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks Sportradar Group AG is worth if the risks below bite instead of the drivers above.
The largest risk is the cost of official league data rights, which come up for renewal every several years and are increasingly priced in cash plus equity stakes, diluting shareholders and pressuring margins. Losing a major rights contract, especially for a top U.S. league, to Genius Sports would be a serious blow to Sportradar's competitive position and valuation. The company reports in euros while a large share of growth is U.S. dollar-denominated, so foreign-exchange swings can mask underlying constant-currency performance, and both Q1 and Q2 2026 showed small net losses despite revenue growth, followed by a cut to 2026 guidance. Regulatory risk cuts both ways: tighter betting rules can shrink the market, while unsettled prediction-market rules make that upside speculative. Sportradar has also drawn short-seller scrutiny (including a Bear Cave report) and faces the longer-term threat that raw sports data becomes commoditized. Sentiment is a risk in its own right: the stock is down about 49% year to date as of October 16, 2026, at least one institutional holder has exited, and some analysts have favored Genius Sports instead, so another miss in the November 4 report could extend the slide.
The bear case deserves the same attention as the bull case, and usually gets less. If you are holding SRAD already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.
Where analysts land on SRAD
22 analysts cover SRAD, with an average target of $18.19 (+52.7% against $11.91) and a split of 16 buy, 7 hold, 0 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the SRAD forecast and price target page.
How is SRAD valued? (as of October 2026)
Snapshot for SRAD as of October 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (TTM): ~€1.39B
- Q2 2026 revenue: ~€378M (~+19% YoY)
- Q2 2026 EPS vs estimate: $0.04 vs ~$0.07
- Operating / net margin: ~10% / ~1%
- Free cash flow (TTM): ~€347M
- P/E trailing / forward: ~197x / ~27x
- Market cap: ~$3.5B
SRAD closes near $11.84 on October 16, 2026, down about 49% year to date and close to its 52-week low of about $11.39. Near-zero reported earnings push the trailing P/E to about 197x, but on cash-flow measures the stock looks far cheaper, at about 6.5x EV/EBITDA and 2.5x sales with net cash on the balance sheet. The gap between strong cash generation and weak reported profit, plus the 2026 guidance cut, is what the market is pricing, and the $170 million Atrium sale adds cash ahead of Q3 results on November 4.
How do you decide if SRAD is a buy?
Rather than asking whether SRAD is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the bull case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold SRAD indirectly through an index or sector ETF before adding more.
What would change your mind on SRAD
Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.
- Bull case breaks if: Duopoly moat in official sports data stalls in the reported numbers rather than in the narrative around them.
- Bear case breaks if: the largest risk is the cost of official league data rights, which come up for renewal every several years and are increasingly priced in cash plus equity stakes, diluting shareholders and pressuring margins fails to materialise over several reporting periods while the drivers keep compounding.
- Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.
For the full picture, see the SRAD stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about SRAD against your real portfolio and see your actual exposure before deciding.
Investing in Sportradar Group AG with AI
Connect the broker you already use and ask Walnut's AI how SRAD fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
Is SRAD a good stock to buy right now?
+
That depends on which case you find more convincing, and both are on this page. The bull case rests on Duopoly moat in official sports data, with revenue (ttm) at ~€1.39B. The bear case rests on the largest risk is the cost of official league data rights, which come up for renewal every several years and are increasingly priced in cash plus equity stakes, diluting shareholders and pressuring margins. Analysts covering it are spread from $13.68 to $35.78, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.
Should I sell SRAD?
+
Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The largest risk is the cost of official league data rights, which come up for renewal every several years and are increasingly priced in cash plus equity stakes, diluting shareholders and pressuring margins. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $13.68, +14.9% from the $11.91 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.
What is the bull case for SRAD?
+
Duopoly moat in official sports data. Sportradar and Genius Sports control the market for official, low-latency sports data that regulated sportsbooks depend on. The most optimistic analyst target on SRAD is $35.78, +200.4% from the $11.91 price. That figure is only reachable if this thesis works close to its best case.
What is the bear case for SRAD?
+
The largest risk is the cost of official league data rights, which come up for renewal every several years and are increasingly priced in cash plus equity stakes, diluting shareholders and pressuring margins. Losing a major rights contract, especially for a top U.S. league, to Genius Sports would be a serious blow to Sportradar's competitive position and valuation. The company reports in euros while a large share of growth is U.S. dollar-denominated, so foreign-exchange swings can mask underlying constant-currency performance, and both Q1 and Q2 2026 showed small net losses despite revenue growth, followed by a cut to 2026 guidance. Regulatory risk cuts both ways: tighter betting rules can shrink the market, while unsettled prediction-market rules make that upside speculative. Sportradar has also drawn short-seller scrutiny (including a Bear Cave report) and faces the longer-term threat that raw sports data becomes commoditized. Sentiment is a risk in its own right: the stock is down about 49% year to date as of October 16, 2026, at least one institutional holder has exited, and some analysts have favored Genius Sports instead, so another miss in the November 4 report could extend the slide. The most pessimistic published target is $13.68, +14.9% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.
What does Sportradar Group AG do?
+
Sportradar Group AG (Nasdaq: SRAD) is a B2B sports technology company that collects, models, and distributes real-time sports data.
What would have to change for SRAD to stop being worth holding?
+
Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Duopoly moat in official sports data) stalling in the reported numbers rather than in the narrative, the risk above (the largest risk is the cost of official league data rights, which come up for renewal every several years and are increasingly priced in cash plus equity stakes, diluting shareholders and pressuring margins) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.
What does Sportradar (SRAD) do?
+
Sportradar is a B2B sports data and betting technology company. It licenses official data from leagues and sells real-time odds, live data feeds, managed trading, integrity monitoring, and marketing services to sportsbooks, casinos, media companies, and leagues. It does not take bets itself.
Is Sportradar a bookmaker or a gambling company?
+
No. Sportradar is an infrastructure and data provider that sits behind bookmakers. Its revenue tracks the overall growth of regulated betting and data demand rather than the win-or-lose outcome of any individual bet, which makes its model different from an operator like DraftKings.
Who are Sportradar's main competitors?
+
Its closest rival is Genius Sports, forming a two-player duopoly for official sports data. Other competition comes from sportsbook technology vendors and from broader sports-media, analytics, and integrity providers competing for adjacent budgets.
Walnut is informational, not investment advice, and gives no verdict on SRAD. Analyst targets referenced here come from a October 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.